Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Dedicated to enhancing knowledge and skill in the care of the allergic patient."

ADVOCACY UPDATES

Your AAOA at the AMA

I want to urge you to consider membership in the AMA because your membership in…

read more

Fall Advocacy Update: USP 797, E/M Documentation and Payment

Revisions to USP Chapter 797 Open for Comment Since the United States Pharmacopeia (USP) released…

read more

Brief Update on the Final CY 2019 Physician Fee Schedule

On November 1, the Centers for Medicare and Medicaid Services released the final Physician Fee…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/2018: Research Grant Cycle
Learn more

04/01/2019: 2019 Fellow Exam Application Deadline
Learn more

06/01/2019: Research Grant Cycle

06/7/19: Membership Application Deadline to be eligible for AAOA Member rate for the 2019 Basic Course

07/31/19: Membership Application Deadline to be voted in at the 2019 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2019 Annual Meeting
Learn more

EDUCATION

Codes/Guidelines

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

IFAR

IFAR Impact Factor: 2.135

aaoaf-ifar

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2019 Interactive Allergy & Rhinology Course
February 8-10, 2019 | Dallas, TX
Learn More and Register

2019 Basic Course in Allergy & Immunology
June 27-29 | Minneapolis, MN
Save the Date

2019 AAOA Annual Meeting
September 13-15 | New Orleans, LA
Save the Date

2019 Advanced Course in Allergy & Immunology
December 12-14 | Austin, TX
Save the Date

AAOA Clinical Insights
Learn More and Register

PATIENT CORNER

OTC Allergy Medications

There seem to be more and more medications available for allergy treatment that  you can now purchase over the counter.
The FDA is allowing previously prescription only drugs to be made available directly to the consumer without a prescription — adding more to the over-the-counter options in the healthcare aisles.

Read More

News and Updates

From the AAOA President, Matthew Ryan, MD

...the AAOA continues to be the organization that Otolaryngologists look to for up-to-date education and information on the…

read more

FDA Approves First Generic Version of EpiPen

The Food and Drug Administration approves the first generic version of EpiPen and EpiPen Jr.…

read more

Social and Networking Events at the 2018 AAOA Annual Meeting

This year’s Annual Meeting assures to be not only educational, interactive, and practice-centered, but also…

read more

Menu
Flu Nasal Spray 840 420

Allergic Rhinitis and Nasal Sprays

As indicated in our mission statement, the AAOA is concerned with advancing the treatment of patients with allergic disease.  When the FDA was considering making Nasacort available over-the-counter, the AAOA surveyed our membership about the topic.

The biggest concerns expressed were ensuring patients were getting an accurate diagnosis of their nasal problems, were given good information about available treatment options, and that they were being monitored long-term for potential side effects of medications, such as nasal steroid sprays.

Nasal steroid sprays are a great treatment option for patients with allergic rhinitis. They are generally considered the most effective class of medications available for treating the four major symptoms of allergic rhinitis, particularly nasal obstruction, runny nose, nasal itching, and sneezing. Now that the FDA has approved the over-the-counter availability of Nasacort, we hope that this will make the nasal steroid treatment option more available and affordable for patients with allergic rhinitis. This is what happened after non-sedating antihistamines became available over-the-counter. The AAOA still stresses the importance of patients receiving a good assessment of their nasal problems to make sure the appropriate treatment options are recommended. If nasal steroid sprays appear to be a good option, for some patients it will be more affordable to buy these over-the-counter.  As of now, patients with prescription drug coverage often still get a better price on generic nasal steroid sprays by prescription, compared to purchasing them over-the-counter.  We still recommend the patients have regular examinations of their nose, typically at least once a year, to make sure there are no complications of persistent nasal steroid spray use.

With the approval of Nasacort, more nasal steroid sprays are likely to become available over the counter. The FDA has already approved the Flonase brand for over-the-counter availability. It has been reported online that Flonase will likely become available in stores over-the-counter in early 2015. As multiple nasal steroid sprays become available over-the-counter, it is possible generic brands will also become available, and hopefully competition will result in lower prices.

 

Leave a Reply

Your email address will not be published. Required fields are marked *